Joe Flynn joined Inotiv in July 2018, having served as chief commercial officer and executive vice president of Seventh Wave Laboratories. Appointed to his current role as chief commercial officer in February 2019, he is responsible for leading sales and marketing efforts across Inotiv’s five sites.
Flynn has had an esteemed career as a senior executive in contract research, with over 25 years of strategic and operational experience focusing on pharmaceutical research and development. Prior to his tenure at Seventh Wave, Flynn was a global vice president of sales and client services for multiple divisions of Covance Laboratories. Prior to Covance, he held operational roles at PPD Inc. and ABC Laboratories (now Eurofins). Flynn is also a board member of the Missouri Biotechnology Association.